Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.560
+0.020 (0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
2.560
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $13.66 million as of April 28, 2026. Its market cap has increased by 33.93% in one year.
Market Cap
13.66M
Enterprise Value
5.04M
1-Year Change
33.93%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $13.66M, a decrease of -80.68%. That is a compound annual growth rate of -15.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 13.60M | 102.99% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 15.26M |
| Vyome Holdings | 14.74M |
| Citius Pharmaceuticals | 14.55M |
| Hoth Therapeutics | 14.33M |
| Phio Pharmaceuticals | 13.94M |
| Jupiter Neurosciences | 13.42M |
| Intensity Therapeutics | 13.19M |
| BioCardia | 12.69M |